Tissue-specific stem cells obtained by reprogramming of Non-obese diabetic (NOD) mouse-derived pancreatic cells confer insulin production in response to glucose

PLoS ONE

Volumn 11, Issue 9, 2016, Pages

  Saitoh, Issei ^a   Sato, Masahiro ^b   Soda, Miki ^a   Inada, Emi ^c   Iwase, Yoko ^a   Murakami, Tomoya ^a   Ohshima, Hayato ^a   Hayasaki, Haruaki ^a   Noguchi, Hirofumi ^d  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

^d UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; ORGANIC CATION TRANSPORTER 3; TRANSCRIPTION FACTOR SOX2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL LINEAGE; CELL RENEWAL; CONTROLLED STUDY; EPIGENETICS; FEMALE; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; IN VITRO STUDY; INDUCED PLURIPOTENT STEM CELL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SYNTHESIS; MALE; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PANCREAS CELL; PLASMID; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84992121932     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0163580     Document Type: Article

References (39)

1. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343(4):230-8. Epub 2000/07/27. doi: 10.1056/NEJM200007273430401 PMID: 10911004.
2. Bonner-Weir S, Weir GC. New sources of pancreatic beta-cells. Nat Biotechnol. 2005;23(7):857-61. Epub 2005/07/09. nbt1115 [pii] doi: 10.1038/nbt1115 PMID: 16003374.
3. Noguchi H. Stem cells for the treatment of diabetes. Endocr J. 2007;54(1):7-16. Epub 2006/10/21. JST. JSTAGE/endocrj/KR-86 [pii]. PMID: 17053295.
4. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663-76. Epub 2006/08/15. S0092-8674 (06) 00976-7 [pii] doi: 10.1016/j.cell.2006.07.024 PMID: 16904174.
5. Hanna J, Wernig M, Markoulaki S, Sun CW, Meissner A, Cassady JP, et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science. 2007;318(5858):1920-3. Epub 2007/12/08. 1152092 [pii] doi: 10.1126/science.1152092 PMID: 18063756.
6. Hanna J, Markoulaki S, Mitalipova M, Cheng AW, Cassady JP, Staerk J, et al. Metastable pluripotent states in NOD-mouse-derived ESCs. Cell Stem Cell. 2009;4(6):513-24. Epub 2009/05/12. S1934-5909 (09) 00169-6 [pii] doi: 10.1016/j.stem.2009.04.015 PMID: 19427283.
7. Wernig M, Zhao JP, Pruszak J, Hedlund E, Fu D, Soldner F, et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci USA. 2008;105(15):5856-61. Epub 2008/04/09. 0801677105 [pii] doi: 10.1073/pnas.0801677105 PMID: 18391196.
8. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, et al. Disease-specific induced pluripotent stem cells. Cell. 2008;134(5):877-86. Epub 2008/08/12. S0092-8674 (08) 01001-5 [pii] doi: 10. 1016/j.cell.2008.07.041 PMID: 18691744.
9. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861-72. Epub 2007/11/24. S0092-8674 (07) 01471-7 [pii] doi: 10.1016/j.cell.2007.11.019 PMID: 18035408.
10. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858):1917-20. Epub 2007/11/22.1151526 [pii] doi: 10.1126/science.1151526 PMID: 18029452.
11. Kroon E, Martinson LA, Kadoya K, Bang AG, Kelly OG, Eliazer S, et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol. 2008;26(4):443-52. Epub 2008/02/22. nbt1393 [pii] doi: 10.1038/nbt1393 PMID: 18288110.
12. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007;448(7151):313-7. Epub 2007/06/08. nature05934 [pii] doi: 10.1038/nature05934 PMID: 17554338.
13. Yamanaka S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell. 2007;1(1):39-49. Epub 2008/03/29. S1934-5909 (07) 00018-5 [pii] doi: 10.1016/j. stem.2007.05.012 PMID: 18371333.
14. Noguchi H, Saitoh I, Tsugata T, Kataoka H, Watanabe M, Noguchi Y. Induction of tissue-specific stem cells by reprogramming factors, and tissue-specific selection. Cell Death Differ. 2015;22(1):145-55. Epub 2014/09/06. doi: 10.1038/cdd.2014. 132 cdd2014132 [pii]. PMID: 25190146; PubMed Central PMCID: PMC4262778.
15. Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, et al. Epigenetic memory in induced pluripotent stem cells. Nature. 2010;467(7313):285-90. Epub 2010/07/21. doi: 10.1038/nature09342 nature09342 [pii]. PMID: 20644535; PubMed Central PMCID: PMC3150836.
16. Polo JM, Liu S, Figueroa ME, Kulalert W, Eminli S, Tan KY, et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol. 2010;28(8):848-55. Epub 2010/07/21. doi: 10.1038/nbt.1667 nbt.1667[pii]. PMID: 20644536; PubMed Central PMCID: PMC3148605.
17. Doi A, Park IH, Wen B, Murakami P, Aryee MJ, Irizarry R, et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet. 2009;41(12):1350-3. Epub 2009/11/03. doi: 10.1038/ng.471 ng.471 [pii]. PMID: 19881528; PubMed Central PMCID: PMC2958040.
18. Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR, Hon G, et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature. 2011;471(7336):68-73. Epub 2011/02/04. doi: 10.1038/nature09798 nature09798 [pii]. PMID: 21289626; PubMed Central PMCID: PMC3100360.
19. Ohi Y, Qin H, Hong C, Blouin L, Polo JM, Guo T, et al. Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat Cell Biol. 2011;13(5):541-9. Epub 2011/04/19. doi: 10.1038/ncb2239 ncb2239 [pii]. PMID: 21499256; PubMed Central PMCID: PMC3987913.
20. Bar-Nur O, Russ HA, Efrat S, Benvenisty N. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell. 2011;9(1):17-23. Epub 2011/07/06. doi: 10.1016/j.stem.2011.06.007 S1934-5909 (11) 00293-1 [pii]. PMID: 21726830.
21. Carey BW, Markoulaki S, Hanna J, Saha K, Gao Q, Mitalipova M, et al. Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc Natl Acad Sci USA. 2009;106(1):157-62. Epub 2008/12/26. 0811426106 [pii] doi: 10.1073/pnas.0811426106 PMID: 19109433.
22. Noguchi H, Oishi K, Ueda M, Yukawa H, Hayashi S, Kobayashi N, et al. Establishment of mouse pancreatic stem cell line. Cell Transplant. 2009;18(5):563-71. Epub 2009/09/25. PMID: 19775518.
23. D'Amour KA, Bang AG, Eliazer S, Kelly OG, Agulnick AD, Smart NG, et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol. 2006;24(11):1392-401. Epub 2006/10/21. nbt1259 [pii] doi: 10.1038/nbt1259 PMID: 17053790.
24. Kaitsuka T, Noguchi H, Shiraki N, Kubo T, Wei FY, Hakim F, et al. Generation of functional insulin-producing cells from mouse embryonic stem cells through 804G cell-derived extracellular matrix and protein transduction of transcription factors. Stem Cells Transl Med. 2014;3(1):114-27. Epub 2013/12/03. doi: 10.5966/sctm.2013-0075 sctm.2013-0075 [pii]. PMID: 24292793; PubMed Central PMCID: PMC3902286.
25. Roep BO, Atkinson M. Animal models have little to teach us about type 1 diabetes: 1. In support of this proposal. Diabetologia. 2004;47(10):1650-6. Epub 2004/10/19. doi: 10.1007/s00125-004-1517-1 PMID: 15490110.
26. Roep BO. Are insights gained from NOD mice sufficient to guide clinical translation? Another inconvenient truth. Ann N Y Acad Sci. 2007;1103:1-10. Epub 2007/03/23. annals.1394.018 [pii] doi: 10.1196/annals.1394.018 PMID: 17376838.
27. von Herrath M, Nepom GT. Animal models of human type 1 diabetes. Nat Immunol. 2009;10(2):129-32. Epub 2009/01/17. ni0209-129 [pii] doi: 10.1038/ni0209-129 PMID: 19148193.
28. Li H, Collado M, Villasante A, Strati K, Ortega S, Canamero M, et al. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature. 2009;460(7259):1136-9. Epub 2009/08/12. nature08290 [pii] doi: 10. 1038/nature08290 PMID: 19668188.
29. Agarwal S, Loh YH, McLoughlin EM, Huang J, Park IH, Miller JD, et al. Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature. 2010;464(7286):292-6. Epub 2010/02/19. doi: 10.1038/nature08792 nature08792 [pii]. PMID: 20164838; PubMed Central PMCID: PMC3058620.
30. Marion RM, Strati K, Li H, Tejera A, Schoeftner S, Ortega S, et al. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell. 2009;4(2):141-54. Epub 2009/02/10. S1934-5909 (09) 00002-2 [pii] doi: 10.1016/j.stem.2008.12.010 PMID: 19200803.
31. Jeanclos E, Krolewski A, Skurnick J, Kimura M, Aviv H, Warram JH, et al. Shortened telomere length in white blood cells of patients with IDDM. Diabetes. 1998;47(3):482-6. Epub 1998/03/31. PMID: 9519758.
32. Hochedlinger K, Plath K. Epigenetic reprogramming and induced pluripotency. Development. 2009;136(4):509-23. Epub 2009/01/27. 136/4/509 [pii] doi: 10.1242/dev. 020867 PMID: 19168672.
33. Davy P, Allsopp R. Balancing out the ends during iPSC nuclear reprogramming. Cell Stem Cell. 2009;4(2):95-6. Epub 2009/02/10. S1934-5909 (09) 00007-1 [pii] doi: 10.1016/j.stem.2009.01.004 PMID: 19200794.
34. Yang X, Smith SL, Tian XC, Lewin HA, Renard JP, Wakayama T. Nuclear reprogramming of cloned embryos and its implications for therapeutic cloning. Nat Genet. 2007;39(3):295-302. Epub 2007/02/28. ng1973 [pii] doi: 10.1038/ng1973 PMID: 17325680.
35. Tateishi K, He J, Taranova O, Liang G, D'Alessio AC, Zhang Y. Generation of insulin-secreting isletlike clusters from human skin fibroblasts. J Biol Chem. 2008;283(46):31601-7. Epub 2008/09/11. M806597200 [pii] doi: 10.1074/jbc. M806597200 PMID: 18782754.
36. Maehr R, Chen S, Snitow M, Ludwig T, Yagasaki L, Goland R, et al. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci USA. 2009;106(37):15768-73. Epub 2009/09/02. 0906894106 [pii] doi: 10.1073/pnas.0906894106 PMID: 19720998.
37. Osafune K, Caron L, Borowiak M, Martinez RJ, Fitz-Gerald CS, Sato Y, et al. Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol. 2008;26(3):313-5. Epub 2008/02/19. nbt1383 [pii] doi: 10.1038/nbt1383 PMID: 18278034.
38. Noguchi H, Matsumoto S, Ueda M, Hayashi S, Kobayashi N, Jackson A, et al. Method for isolation of mouse pancreatic stem cells. Transplant Proc. 2008;40(2):422-3. Epub 2008/04/01. S0041-1345 (08) 00008-0 [pii] doi: 10.1016/j.transproceed.2008.01.007 PMID: 18374088.
39. Noguchi H, Matsushita M, Okitsu T, Moriwaki A, Tomizawa K, Kang S, et al. A new cell-permeable peptide allows successful allogeneic islet transplantation in mice. Nat Med. 2004;10(3):305-9. Epub 2004/02/11. doi: 10.1038/nm994 nm994 [pii]. PMID: 14770176.